Institut Pasteur Korea (IPK) is an international research institute focused on addressing global health issues with a combination of cutting edge approaches in order to understand disease mechanisms and develop new treatments. By promoting multi-disciplinary projects, IPK is at the forefront of drug discovery and contributes to Korea’s future scientific resources through research, education and technological innovation.
The institute was established in April 2004 in collaboration with Institut Pasteur Paris and the Korea Institute of Science and Technology (KIST), with support from the Ministry of Science and ICT (MSIT). IPK also has a great supporter in the Gyeonggi Provincial government (2005 – 2015 : Block funding | 2016 – Present : drug discovery co-resarch fund for pharm industries).
IPK is a private, non-profit foundation with four core missions of public interest – Research, Education, Public Health, and Translation of biomedical discoveries to improve health via technology transfer and industrial partnerships.
IPK is a growth engine for Korea’s biomedical research industry, working successfully with biotech to develop multi-disciplinary R&D and translate fundamental discovery-based research to enhance human, animal and environmental health.
In keeping with Louis Pasteur’s belief, “There are sciences and the applications of science, bound together as the fruit of the tree which bears it”, IPK combines front line biology, IT, and chemistry, with innovative cell-based drug discovery platforms that identify novel molecular targets for potential new therapies to treat diseases. With world-class drug discovery capabilities and a talented team drawn from all over the world, IPK scientists aim to uncover various physiological and pathological processes to devise new strategies for diagnosing, preventing and treating disease. IPK currently focuses on global infectious diseases that represent today’s health challenges such as tuberculosis, antibiotic resistance, hepatitis, influenza, cancer, dengue and neglected diseases, as well as preparing for emerging diseases that may impact future health needs.
IPK is committed to contributing to Korea’s scientific intellectual and technical resources by establishing relevant domestic partnerships with research institutions, academia and industry. IPK recognizes the important role universities and biotech companies’ play in research and development of novel drugs and that the future of drug development hinges on the innovative and cooperative efforts of public and private organizations.
To date, the IPK team is approximately 100 strong, working in research laboratories, core technological facilities, project management and administration.
Find out more about IPK’s success story and our Inventions & Technologies
Education and teaching are an important part of Louis Pasteur’s legacy and the establishment of IPK. The institute contributes to Korea’s knowledge economy, fanning the spirit of discovery and innovation by nurturing the development of the next generation of scientists and health professionals.
IPK is committed to sharing scientific expertise and technologies with early career researchers and scientists. IPK provides a variety of educational and training opportunities throughout the year, such as internships for undergraduate and graduate students, international practical courses for select scientists with support from the Institut Pasteur International Network, and a Doctoral program (UST-IPK Campus).
At the community level, IPK’s educational programing sparks an interest in science and seeds the importance of research in middle and high school students by offering Life Science Classes, opening IPK to school field trips and mentoring science club students.
Learn more about IPK’s Educational Programs and find a program that fits your needs.
IPK is a member of the Institut Pasteur International Network (Network) and actively involved in research on global infectious diseases. IPK stands ready to work in collaboration with national and international health authorities such as the Centers for Disease Control & Prevention (KCDC) and the World Health Organization (WHO), providing expertise in infectious diseases to uncover the basic biology of disease and discover effective countermeasures.
In 2015, when an outbreak of MERS occurred in Korea, IPK brought its expertise in infectious diseases to discover effective countermeasures against the causative virus. With an agreement with the Korean government, IPK uses screening technologies in its high security laboratories to test existing therapeutic molecules already approved by health authorities.
Learn how IPK’s Discovery Biology Laboratories are working to improve health.
Present on 5 continents, through 33 institutes, the Institut Pasteur International Network (Network) plays a major role in research, education and public health via numerous cooperation and training programs and provides a front-line response against emerging, re-emerging and endemic infectious diseases.
As a hub institution, IPK plays a key role in the Network and serves as a bridge between Korea and global bio-pharma science. For over a decade, IPK has forged successful partnerships and expanded Korea’s R&D base collaborative research projects with global alliances. Since 2007, IPK has worked in association with Drugs for Neglected Diseases initiative (DNDi), a collaborative, and patients’ needs-driven, non-profit organization to develop new treatments for neglected diseases, and has received award recognition multiple times throughout the years for excellence in research and commitment to global health. IPK also promotes scientific exchanges through internships, international seminars and conferences.
As a private, non-profit organization, IPK relies on funding and support from a number of sources including Ministry of Science and ICT (MSIT), Gyeonggi Provincial government (2005 – 2015 : Block funding | 2016 – Present : drug discovery co-resarch fund for pharm industries), national and international grants and projects as well as donations from private citizens.
With your generous donation, together, we can make a difference in the lives of millions of people suffering from a wide range of infectious disease, today and in the future.